Precigen Stock Performance
| PGEN Stock | USD 4.53 0.07 1.57% |
On a scale of 0 to 100, Precigen holds a performance score of 3. The company holds a Beta of 0.14, which implies not very significant fluctuations relative to the market. As returns on the market increase, Precigen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Precigen is expected to be smaller as well. Please check Precigen's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Precigen's historical price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Precigen displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (5.71) | Five Day Return (8.98) | Year To Date Return 4.21 | Ten Year Return (84.54) | All Time Return (81.11) |
1 | A Fresh Look at Precigen Valuation Following Q3 Revenue Growth and Widened Net Loss | 11/14/2025 |
2 | Disposition of 1079137 shares by Helen Sabzevari of Precigen subject to Rule 16b-3 | 12/02/2025 |
3 | Disposition of 235467 shares by Kindler Jeffrey B of Precigen at 3.6349 subject to Rule 16b-3 | 12/12/2025 |
4 | Spotlighting Bridgewater Bancshares And 2 Other Growth Stocks With Strong Insider Ownership - simplywall.st | 12/16/2025 |
5 | Disposition of 9931 shares by Kirk Randal J of Precigen at 4.18 subject to Rule 16b-3 | 12/22/2025 |
6 | Precigen Advances Genetic Medicine Platforms | 12/29/2025 |
7 | Precigen Shares Down 6.1 percent Heres What Happened | 01/05/2026 |
8 | Precigen, Inc. Stock Analysis Biotechnology Innovator With Potential 84 percent Upside - DirectorsTalk Interviews | 01/09/2026 |
9 | Assessing Precigen Valuation After PAPZIMEOS Commercial Momentum And EMA Milestone | 01/15/2026 |
10 | New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory P... | 01/20/2026 |
| Begin Period Cash Flow | 7.8 M | |
| Total Cashflows From Investing Activities | -20.7 M |
Precigen Relative Risk vs. Return Landscape
If you would invest 414.00 in Precigen on October 31, 2025 and sell it today you would earn a total of 32.00 from holding Precigen or generate 7.73% return on investment over 90 days. Precigen is currently generating 0.268% in daily expected returns and assumes 5.518% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Precigen, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Precigen Target Price Odds to finish over Current Price
The tendency of Precigen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.53 | 90 days | 4.53 | about 15.24 |
Based on a normal probability distribution, the odds of Precigen to move above the current price in 90 days from now is about 15.24 (This Precigen probability density function shows the probability of Precigen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Precigen has a beta of 0.14 indicating as returns on the market go up, Precigen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Precigen will be expected to be much smaller as well. Additionally Precigen has an alpha of 0.1879, implying that it can generate a 0.19 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Precigen Price Density |
| Price |
Predictive Modules for Precigen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Precigen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Precigen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Precigen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Precigen is not an exception. The market had few large corrections towards the Precigen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Precigen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Precigen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.19 | |
β | Beta against Dow Jones | 0.14 | |
σ | Overall volatility | 0.38 | |
Ir | Information ratio | 0.02 |
Precigen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Precigen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Precigen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Precigen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 3.92 M. Net Loss for the year was (126.23 M) with loss before overhead, payroll, taxes, and interest of (52.67 M). | |
| Precigen currently holds about 115.3 M in cash with (68.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. | |
| Precigen has a frail financial position based on the latest SEC disclosures | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from prnewswire.com: New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis |
Precigen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Precigen Stock often depends not only on the future outlook of the current and potential Precigen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Precigen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 267.7 M | |
| Cash And Short Term Investments | 97.9 M |
Precigen Fundamentals Growth
Precigen Stock prices reflect investors' perceptions of the future prospects and financial health of Precigen, and Precigen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precigen Stock performance.
| Return On Equity | -6.68 | ||||
| Return On Asset | -0.67 | ||||
| Operating Margin | (32.54) % | ||||
| Current Valuation | 1.65 B | ||||
| Shares Outstanding | 352.91 M | ||||
| Price To Earning | (2.06) X | ||||
| Price To Book | 39.97 X | ||||
| Price To Sales | 250.13 X | ||||
| Revenue | 3.92 M | ||||
| Gross Profit | (52.67 M) | ||||
| EBITDA | (123.5 M) | ||||
| Net Income | (126.23 M) | ||||
| Cash And Equivalents | 115.3 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 5.5 M | ||||
| Debt To Equity | 3.73 % | ||||
| Current Ratio | 5.51 X | ||||
| Book Value Per Share | (0.12) X | ||||
| Cash Flow From Operations | (68.17 M) | ||||
| Earnings Per Share | (0.41) X | ||||
| Market Capitalization | 1.36 B | ||||
| Total Asset | 145.27 M | ||||
| Retained Earnings | (2.09 B) | ||||
| Working Capital | 80.9 M | ||||
| Current Asset | 285.72 M | ||||
| Current Liabilities | 66.91 M | ||||
About Precigen Performance
By examining Precigen's fundamental ratios, stakeholders can obtain critical insights into Precigen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Precigen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 19.00 | 18.05 | |
| Return On Tangible Assets | (1.19) | (1.13) | |
| Return On Capital Employed | (1.25) | (1.19) | |
| Return On Assets | (1.00) | (0.95) | |
| Return On Equity | (3.77) | (3.58) |
Things to note about Precigen performance evaluation
Checking the ongoing alerts about Precigen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precigen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Precigen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 3.92 M. Net Loss for the year was (126.23 M) with loss before overhead, payroll, taxes, and interest of (52.67 M). | |
| Precigen currently holds about 115.3 M in cash with (68.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. | |
| Precigen has a frail financial position based on the latest SEC disclosures | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from prnewswire.com: New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis |
- Analyzing Precigen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precigen's stock is overvalued or undervalued compared to its peers.
- Examining Precigen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Precigen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precigen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Precigen's stock. These opinions can provide insight into Precigen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Biotechnology sector continue expanding? Could Precigen diversify its offerings? Factors like these will boost the valuation of Precigen. Anticipated expansion of Precigen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Precigen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth 0.194 | Return On Assets | Return On Equity |
Investors evaluate Precigen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Precigen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Precigen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Precigen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precigen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Precigen's market price signifies the transaction level at which participants voluntarily complete trades.